Dovitinib lactate
商品编号:
TL0070
备注:
库存充足,如需更大包装,请联系销售人员,大包装有极大的折扣优惠!
详细介绍
l 基本信息 |
产品名称 | 多韦替尼乳酸盐(Dovitinib lactate) |
一般描述 | Dovitinib Lactate is lactate salt of
Dovitinib with potential antineoplastic activity. |
别 称 | (3E)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one;2-hydroxypropanoic
acid;hydrate; TKI258; Dovitinib lactate monohydrate; |
纯 度 | ≥98%(HPLC) | CAS NO. | 915769-50-5 |
分子式 | C24H29FN6O5 | 分子量 | 500.531 |
适用范围 | 生物试剂,适用于细胞培养等 |
l 理化信息 |
外 观 | 浅黄绿色或绿色固体 |
溶解性(25℃) | DMSO | ≥50mg/mL |
乙醇 | ~1mg/mL |
水 | ≥25mg/mL |
l 生物学信息 |
生物活性/药理作用 | Dovitinib Lactate is the orally
bioavailable lactate salt of a benzimidazole-quinolinone compound with potential antineoplastic activity. Dovitinib strongly binds to fibroblast
growth factor receptor 3 (FGFR3) and inhibits its phosphorylation, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell death. In addition, this agent may inhibit other members of the RTK superfamily, including the vascular endothelial growth factor receptor; fibroblast growth factor receptor 1; platelet-derived growth factor receptor type 3; FMS-like tyrosine kinase 3; stem cell factor receptor (c-KIT); and colony-stimulating factor receptor 1; this may result in an additional reduction in cellular proliferation and angiogenesis, and the induction of tumor cell apoptosis. The activation of FGFR3 is associated with cell proliferation and survival in certain cancer cell types. |
l 包装与存储 |
包 装 | 5mg; 100mg |
存储温度 | 0-5℃ |
l 注意事项及免责声明 |
本产品仅用于实验研究,不得作为药物使用,不得用于家用或其它用途。 |
l 参考文献 |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |